Please login to the form below

Not currently logged in
Email:
Password:

Covid-19

This page shows the latest Covid-19 news and features for those working in and with pharma, biotech and healthcare.

MHRA approves second COVID-19 antibody treatment

MHRA approves second COVID-19 antibody treatment

The UK regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), has approved a second antibody treatment against COVID-19. ... In trials, a single dose of Xevudy reduced the risk of hospitalisation and death by 79% in high-risk adults

Latest news

  • Annual COVID-19 jabs likely, says Pfizer head Annual COVID-19 jabs likely, says Pfizer head

    Pfizer CEO predicts annual jabs will be needed to maintain a ‘very high level of protection’ against COVID-19 and emphasises the need to vaccinate children. ... He believes that people will need to have annual vaccinations against COVID-19 in order

  • Roche acquires test maker TIB Molbiol Roche acquires test maker TIB Molbiol

    There was a time when few non-scientists had heard of PCR (polymerase chain reaction) tests but now, in the age of COVID-19, the term has entered everyday language.

  • Sanofi to buy acne specialist Origimm Sanofi to buy acne specialist Origimm

    Following the success of the Pfizer-BioNTech and Moderna COVID-19 vaccines, mRNA technology is increasingly being seen as the future of immunotherapy, with many pharmaceutical companies investing in the area.

  • Booster plans expanded to combat Omicron Booster plans expanded to combat Omicron

    As booster jab campaigns against COVID-19 are expanded in many countries, data from Israel backs up the benefits of being boosted. ... Across Europe, countries were already expanding their booster rollouts prior to the arrival of Omicron due to a surge

  • US regulators set to approve oral antiviral against COVID-19 US regulators set to approve oral antiviral against COVID-19

    Oral antiviral treatments that combat the worst effects of COVID-19 are under the regulatory microscope in the US this month. ... Oral medications like molnupiravir and Paxlovid are significantly more convenient than the injectable COVID-19 treatments

More from news
Approximately 532 fully matching, plus 120 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 16 fully matching, plus 121 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Cancer: Beyond the Backlog Cancer: Beyond the Backlog

    Vision. As we enter winter, with new Covid-19 variants emerging and a significant backlog to tackle there is a once in a generation opportunity for the Government and NHS leaders

  • Lucid Group: Orange the World

    Nearly 1 in 3 women have been abused in their lifetime, and since the outbreak of COVID-19, violence against women, particularly domestic violence, has intensified.

  • Committing time to making meaningful connections - top 5 tips Committing time to making meaningful connections - top 5 tips

    Lorna Allen, Involvement Manager for the Cystic Fibrosis Trust, and mother to a CF daughter, echoed these thoughts and added that with everyone moving online in response to the COVID-19 ... COVID. Therefore, it’s even more important that they see a

  • Black community representation in clinical trials Black community representation in clinical trials

    This Black History Month, we discuss the black representation in clinical trials and the effects COVID-19 has had on the black community. ... 4]. COVID-19. Coronavirus (COVID-19) has had a devastating impact on countries around the world.

  • Is COVID-19 yet another barrier to contraceptive access? Is COVID-19 yet another barrier to contraceptive access?

    In this blog, we’re revisiting the concerns raised in our 2020 MAGNIFI around women’s access to contraceptives in the UK and beyond alongside the influence of the COVID-19 ... Alongside revisiting the stock issues that were prevalent at the start of

More from PMHub
Approximately 91 fully matching, plus 207 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...